Harry Lamble

Current Organisation: SENSE BIODETECTION LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£97,007

Oct 14 - Mar 16

Novel Technologies for the Diagnosis of Influenza and Other Infectious Diseases at the Point-of-Care.

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

£355,691

Jan 17 - Dec 18

Development of a Single-Use Molecular Point-of-Care Diagnostic Test for Influenza and RSV

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

£20,889

Dec 16 - Mar 17

A UK - India Collaboration to Drive Innovation in Cervial Cancer Screening

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

£69,838

May 17 - Apr 18

Novel Technologies for a Rapid, Single-Use Cervical Cancer Screening Test.

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

£1,749,592

Apr 19 - Jun 21

Development of an instrument-free molecular diagnostic test for Influenza and RSV

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

£99,994

Nov 15 - Jan 17

Novel technologies for profiling of colorectal cancer biomarkers at the point-of-care.

Innovate UK award to SENSE BIODETECTION LIMITED and Harry Lamble

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}